DE3875107T2 - Verwendung von fructose-1,6-diphosphat zur behandlung von akuten alkoholvergiftungen und chronischem alkoholismus und verwandte pharmazeutische zusammensetzungen. - Google Patents

Verwendung von fructose-1,6-diphosphat zur behandlung von akuten alkoholvergiftungen und chronischem alkoholismus und verwandte pharmazeutische zusammensetzungen.

Info

Publication number
DE3875107T2
DE3875107T2 DE8888109744T DE3875107T DE3875107T2 DE 3875107 T2 DE3875107 T2 DE 3875107T2 DE 8888109744 T DE8888109744 T DE 8888109744T DE 3875107 T DE3875107 T DE 3875107T DE 3875107 T2 DE3875107 T2 DE 3875107T2
Authority
DE
Germany
Prior art keywords
diphosphate
fructose
pharmaceutical compositions
treating acute
chronic alcoholism
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8888109744T
Other languages
English (en)
Other versions
DE3875107D1 (de
Inventor
Ugo Cavicchia
Marco Chiapparelli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomedica Foscama Industria Chimico Farmaceutica SpA
Original Assignee
Biomedica Foscama Industria Chimico Farmaceutica SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomedica Foscama Industria Chimico Farmaceutica SpA filed Critical Biomedica Foscama Industria Chimico Farmaceutica SpA
Application granted granted Critical
Publication of DE3875107D1 publication Critical patent/DE3875107D1/de
Publication of DE3875107T2 publication Critical patent/DE3875107T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • C07H11/04—Phosphates; Phosphites; Polyphosphates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DE8888109744T 1988-04-11 1988-06-18 Verwendung von fructose-1,6-diphosphat zur behandlung von akuten alkoholvergiftungen und chronischem alkoholismus und verwandte pharmazeutische zusammensetzungen. Expired - Fee Related DE3875107T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT47834/88A IT1219919B (it) 1988-04-11 1988-04-11 Impiego del fruttosio-1,6-difosfato nel trattamento della intossicazione alcolica acuta e dell' etilismo cronico e composizioni farmaceutiche relative

Publications (2)

Publication Number Publication Date
DE3875107D1 DE3875107D1 (de) 1992-11-05
DE3875107T2 true DE3875107T2 (de) 1993-02-25

Family

ID=11262826

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888109744T Expired - Fee Related DE3875107T2 (de) 1988-04-11 1988-06-18 Verwendung von fructose-1,6-diphosphat zur behandlung von akuten alkoholvergiftungen und chronischem alkoholismus und verwandte pharmazeutische zusammensetzungen.

Country Status (6)

Country Link
US (1) US4870057A (de)
EP (1) EP0337003B1 (de)
JP (1) JPH01261331A (de)
AT (1) ATE81008T1 (de)
DE (1) DE3875107T2 (de)
IT (1) IT1219919B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5296241A (en) * 1991-04-03 1994-03-22 Brimberg Barnett J Therapeutic composition and method of using same for treatment of hangover
KR970008105B1 (ko) * 1993-06-28 1997-05-21 주식회사 미원 L-아스파테이트 또는 아스파라긴을 유효성분으로 함유하는 알콜성 장해 보호제 및 그의 제조방법
US5731291A (en) * 1996-05-08 1998-03-24 Cypros Pharmaceutical Corp. Partially lyophilized fructose-1,6-diphosphate (FDP) for injection into humans
US6076528A (en) * 1996-05-09 2000-06-20 Cypros Pharmaceutical Corp. Injection of fructose-1,6-diphosphate (FDP) prior to coronary artery bypass grafting surgery
US5944020A (en) * 1997-02-25 1999-08-31 Cypros Pharmaceutical Corp. Use of fructose-1 6-diphosphate as an inotrope drug after cardiopulmonary bypass surgery
US6074658A (en) * 1997-10-03 2000-06-13 Cypros Pharmaceutical Corp. Treatment of sickle cell anemia crises with fructose-1, 6-diphosphate as an analgesic drug
KR100412114B1 (ko) * 2001-07-09 2003-12-24 주식회사 태평양 프럭토스-1,6-디포스페이트 유도체 및 이의 제조방법
FR2955315B1 (fr) 2010-01-19 2012-02-03 Harry Plast Enveloppe avec protection pour objet fragile

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3066135A (en) * 1959-10-03 1962-11-27 Biomedica Int Process for the preparation of hexose alkali metal salts of hexose diphosphate from insoluble salts thereof
GB1134062A (en) * 1964-11-25 1968-11-20 Colonial Sugar Refining Co Water-soluble phosphate compositions and process for preparing
FR6065M (de) * 1966-11-25 1968-05-27
US3931402A (en) * 1970-12-02 1976-01-06 Societa Prodotti Antibiotici S.P.A. Preparations containing hexoses
US4058601A (en) * 1974-07-11 1977-11-15 Chugai Seiyaku Kabushiki Kaisha Method for treating alcoholism
FR2340725A1 (fr) * 1976-02-13 1977-09-09 Somachim Sa Compositions nouvelles contre les effets de l'alcool ethylique ingere
IT1143956B (it) * 1980-03-12 1986-10-29 Foscama Biomed Chim Farma Preparato di fruttosio-1,6-difosfato ad azione protettiva della membrana degli eritrociti in pazienti sottoposti a circolazione extracorporea
US4546095A (en) * 1980-07-21 1985-10-08 Markov Angel K Use of fructose-1,6-diphosphate for treating myocardial infarction
DE3115348A1 (de) * 1981-04-15 1982-12-02 Waldemar 8201 Thansau Leonhard Getraenk, enthaltend fructose und vitamin c, zur beschleunigten senkung des blutalkoholspiegels sowie verfahren zur herstellung des getraenks
FR2549372A1 (fr) * 1983-07-18 1985-01-25 Foscama Biomed Chim Farma Medicament contenant un sel de fructose-1,6-diphosphate utile dans le traitement des angeites
US4703040A (en) * 1985-04-03 1987-10-27 Markov Angel K Treatment of adult respiratory distress syndrome (ARDS) using fructose diphosphate (FDP)

Also Published As

Publication number Publication date
ATE81008T1 (de) 1992-10-15
EP0337003A3 (en) 1990-08-16
DE3875107D1 (de) 1992-11-05
EP0337003A2 (de) 1989-10-18
IT8847834A0 (it) 1988-04-11
IT1219919B (it) 1990-05-24
US4870057A (en) 1989-09-26
JPH01261331A (ja) 1989-10-18
EP0337003B1 (de) 1992-09-30

Similar Documents

Publication Publication Date Title
DK375588D0 (da) Methylenphosphonalkylphosphinsyreforbindelser og farmaceutiske sammensaetninger indeholdende samme
NO914792D0 (no) Gallesyrederivater, deres fremstilling og anvendelse som legemiddel
BR9714517A (pt) Cicloalquila, lactama, lactona e compostos correlatos, composições farmacêuticas compreendendo os mesmos e processos para inibir liberação de peptìdeo beta-amilóide e/ou sua sìntese por uso de tais compostos
BR9809342A (pt) Composto, composição farmacêutica, e, uso do composto
MX9207078A (es) Composiciones de asfalto y concreto de asfalto que contienen azufre.
DE3740152A1 (de) Cyclohexanderivate und zusammensetzungen, welche diese enthalten
ATE92523T1 (de) Verfahren zur abtrennung und reinigung von sialyl-transferasen.
DE3875107D1 (de) Verwendung von fructose-1,6-diphosphat zur behandlung von akuten alkoholvergiftungen und chronischem alkoholismus und verwandte pharmazeutische zusammensetzungen.
DK0559079T3 (da) Substituerede aminophosphonatderivater, fremgangsmåde til fremstilling deraf samt farmaceutiske præparater indeholdende derivaterne
NO875305L (no) Difosfonatforbindelser og fremgangsmaate for deres fremstilling.
RU93053905A (ru) Оксипуриновые нуклеозиды и родственные им соединения, а также их ацильные производные для улучшения гемопоэза, фармацевтическая композиция и способ лечения и/или профилактики
FR2572399B1 (fr) Nouveaux derives de l'adamantanamine, leurs procedes de preparation et medicaments les contenant
BR0008778A (pt) Análogos de prostaglandinas seletivos para fpc16 insaturados
JPS6470417A (en) Method and composition for treating psoriasis
ES2164050T3 (es) Preparacion de compuestos de interleuquina-6.
FR2653771B1 (fr) Procede de preparation de l'azt (azido-3'-desoxy-3'-thymidine) et de composes apparentes.
UA26443A (uk) Похідhі 20,21-диhоребурhамеhіhу, їх рацемати або оптичhі ізомери, або їх адитивhі солі з оргаhічhими кислотами, що мають hоотропhі та аhтидепресивhі властивості
NO913683L (no) Fremgangsmaate for fremstilling av kalsiumopptaksinhibitorer.
SE8602060D0 (sv) Farmaceutiska kompositioner som innehaller reducerad glutation
BR9704686A (pt) Grupos de bactérias e composição farmacêutica contendo tais grupos, e uso da mesma para impedir e tratar doenças associadas com, ou causadas pelo metabolismo alterado de ácido de bìlis.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee